Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review
Journal of Pediatric Gastroenterology and Nutrition · 2025
DOI: 10.1002/jpn3.70197 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Ohad Atia und 22 weiteren Autor:innen. Beteiligte Einrichtung: Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University …. Hauptthemen laut MEDLINE: Crohn Disease, Tumor Necrosis Factor-alpha, Transcriptome. Die Arbeit nennt 21 Literaturangaben. Gefördert von: IOIBD.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
There is a paucity of validated predictors of response to anti‐tumor necrosis factor (TNF) in pediatric Crohn's disease (CD). We aimed to evaluate the predictive utility of intestinal gene expression to predict response to anti‐TNF in children with CD.
Methods
We enrolled children with CD before initiating anti‐TNF as part of the prospective biobank of the pediatric inflammatory bowel disease Porto group of ESPGHAN. Genes potentially associated with therapeutic response were first preselected from a systematic literature review. Ribonucleic acid was extracted and sequenced from inflamed ileal biopsies of 20 children before initiating anti‐TNF (13 with steroid‐free remission [SFR] at 12 months, and seven with primary nonresponse [PNR]). An external validation cohort including 22 children (21 SFR, 1 PNR) was enrolled from Germany and Canada. Using maximum relevance‐minimum redundancy (mRMR) methods, we constructed a support vector machine‐learning model evaluated via leave‐one‐out cross‐validation and permutation testing.
Results
Of 1799 studies identified in the systematic review, 24 met the inclusion criteria, reporting on 150 genes possibly associated with anti‐TNF response in children or adults. In the Porto group cohort, 30 genes were associated with treatment response, of which five (TREM1, IL23R, CCL7, IL17F, and YES1) were most frequently selected. A multivariable model of these genes achieved high predictive utility (area under receiver operating characteristic curve: 0.88 [95% confidence interval: 0.69–1.0], sensitivity/specificity/positive predictive value/negative predictive value: 92%/71%/86%/83%). The same genomic signature in external validation achieved accuracy of 82% (i.e., 18/22 samples were classified correctly, including the single PNR patient).
Conclusion
Increased expression of five genes is associated with higher rate of anti‐TNF response in pediatric CD. Prospective studies are now warranted to validate these genes as biomarkers for treatment selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital LMU, Munich, Germany.
- Department of Pediatrics, Centre de Recherche du CHU Sainte-Justine and University of Montreal, Montréal, Quebec, Canada.
- Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Paediatric Department, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Pediatric Hepatology Gastroenterology and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.
ORCID-Profile: Ohad Atia
Förderung
- IOIBD
Zitieren
APA
Atia, O., Azulay, A., Focht, G., Ledder, O., Lev-Tzion, R., Schwerd, T., Siebert, K., Faro, T., Chapuy, L., Groleau, V., Grzywacz, K., Amar, S., Moalem, B., Michailevitch, R., Bergel, M., Norsa, L., Aloi, M., Kubat, M., Bronsky, J., …, & Turner, D. (2025). Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70197
Vancouver
Atia O, Azulay A, Focht G, Ledder O, Lev-Tzion R, Schwerd T, et al. Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70197
BibTeX
@article{Atia2025,
author = {Atia, Ohad and Azulay, Asaf and Focht, Gili and Ledder, Oren and Lev-Tzion, Raffi and Schwerd, Tobias and Siebert, Kolja and Faro, Tim and Chapuy, Laurence and Groleau, Véronique and Grzywacz, Kelly and Amar, Soumaya and Moalem, Botros and Michailevitch, Ronen and Bergel, Michael and Norsa, Lorenzo and Aloi, Marina and Kubat, Michal and Bronsky, Jiri and Walsh, Patrick T and Hussey, Seamus and Ben-Zvi, Danny and Turner, Dan},
title = {Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
doi = {10.1002/jpn3.70197}
}
EUVIMED